Terminally Ill Adults (End of Life) Bill Committee

The session scrutinised the Terminally Ill Adults (End of Life) Bill, focusing on delivery through the NHS, funding for palliative care, safeguards, and the compatibility of the Bill with existing healthcare frameworks. Government witnesses outlined the principle that primary legislation should set foundations with detailed provisions via secondary legislation, and confirmed the Government’s commitment to implement the Bill if Parliament passes it. They also highlighted funding measures for palliative care, the intended free-at-point-of-use NHS service, and the envisaged four-year commencement period. Key concerns included potential bureaucratic complexity, the balance between safeguarding and access, and the need for robust mental-capacity protections. The session also explored private-sector involvement, advertising restrictions, and the risk of inequitable access. A subsequent session with the Children’s Commissioner raised strong cautions about the Bill’s impact on vulnerable children, the need for EHCP protections through age 25, and online harms in the digital environment. A third session drawing on New Zealand experience warned about expansion of safeguards and the interaction between palliative care and assisted dying, emphasizing whether safeguards ever become prohibitions and the importance of integrating bereavement support. The combined evidence yields government commitments to implement Parliament’s will, a preference for simplicity in regulations, and a recognition that detailed operational models will be shaped through regulations and future debate, while raising concerns about costs, equity, workforce training, and child protection safeguards.

In Meeting 6, MPs/Lords scrutinised the Terminally Ill Adults (End of Life) Bill with witnesses from MHRA, the Royal Pharmaceutical Society (RPS), and legal/regulatory bodies. Key strands included: (a) regulatory roles and independence of MHRA vs government, (b) the evidence base and governance for approved substances (and potential involvement of MHRA vs other regulators), (c) supply mechanisms, liability, and opt-in/opt-out considerations for pharmacists and other health professionals, (d) the need for robust training, governance, and international evidence, (e) concerns about capacity tests, panel design, and potential human-rights implications, and (f) calls for clearer definitions of “pressure” and stronger legal-aid/support for individuals navigating the process. Government position explicitly remains neutral on assisted dying, a point repeatedly reaffirmed by witnesses, while panel design, safeguarding, and capacity questions stress detailed legislative and regulatory clarity ahead of implementation.

In Meeting 5 (2025-10-30) of the Terminally Ill Adults (End of Life) Bill Committee, witnesses pressed for stronger safeguarding against coercion and discrimination in end-of-life decisions, with a focus on disabled people and victims of domestic abuse. Academics, mental-health advocates, and disability-rights representatives argued for a mandatory, multidisciplinary assessment framework; background checks; robust definitions of coercion; and independent advocates at every stage. They urged pre-implementation evaluation of health, social care, and palliative-care capacity before the Bill enters force; highlighted potential risks from online- and institution-driven pressure; and warned against relying on a fixed six-month prognosis as a safeguard. The EHRC and disability-rights voices called for the rights of disabled people to be central, alongside stronger data, accountability, and representation on decision-making panels. The discussion also covered international experience, the need for better palliative care funding, and how safeguards should be designed to prevent discrimination or coercion, while considering the political choices Parliament faces regarding passage of the Bill.

This session of the Terminally Ill Adults (End of Life) Bill inquiry scrutinised safeguards, equity of access, and the role of palliative and end-of-life care in the context of potential assisted dying. Witnesses from Hospice UK, Care England, the Association for Palliative Medicine, King’s College London, and the British Geriatrics Society articulated policy positions and concerns about implementation, funding, and inequities. Key themes included the need for a national policy to protect universal palliative-care access, the risk of widening inequalities if care is under-resourced, opposition or cautions about a fully medicalised model, and calls for robust safeguarding, training, and multi-disciplinary assessments. No explicit UK Government commitment was stated during this session; witnesses urged government action on funding, policy coherence, and clear delivery models ahead of any legislative change.

During the Ad-Hoc Meeting on 2025-10-29, Lords scrutinised the Government’s stance and the practicalities of the Terminally Ill Adults (End of Life) Bill. Key topics included government neutrality vs. sponsor/parliament policy choices, funding implications for the new voluntary assisted dying commissioner and legal panels, and how the panel will operate (not a court or tribunal but an administrative eligibility determination with inquisitorial steps). The witnesses stressed deliverability if enacted, highlighted the impact assessment’s findings (including recruitment and justice-system implications), and acknowledged safeguards around coercion and abuse, training requirements for panel members, and potential judicial-review avenues. Debates covered the default use of medical examiners versus coroners, potential NHS delivery versus mixed provision, cross-border learning from Australia, and safeguarding challenges in prisons. The ministers signalled ongoing technical support to sponsors, while repeatedly noting that funding, delegated powers, and delivery arrangements would be resolved through Parliament and associated departments. The session also touched on safeguarding to address violence against women and girls, and the possibility of a coroner investigation if concerns arise post-death. In sum, MPs and Lords pressed for clarity on funding, delivery models, legal definitions, and safeguarding, while MoJ witnesses asserted deliverability and stressed policy decisions rest with Parliament and sponsors plus the need for further legal advice where necessary.

The committee scrutinised the design and safeguards of the Terminally Ill Adults (End of Life) Bill through two expert panels. The first panel, comprising psychiatrists and social-work professionals, pressed for stronger safeguards, clearer panel functions, and a genuinely multidisciplinary assessment approach to capacity and unmet mental-health needs, arguing that the current panel model is not equivalent to a multidisciplinary clinical team. They called for expanded medical membership on panels, explicit safeguarding powers, early holistic assessments, and unanimous-panel decisions. They also urged opt-in professional involvement with training to address unconscious bias and recommended a series of 10 practical recommendations to improving the Bill. The second panel, focused on medico-legal oversight, warned that removing coroner oversight would be a retrograde step, emphasising the continuing need for coroner/medical examiner roles, robust training, and clear documentation to protect families and detect abuse or coercion. NHS England maintained a neutral stance on principle but signalled readiness to implement if Parliament passes the Bill, including workforce training and guidance for medical examiners. The witnesses highlighted the central tension between enabling patient autonomy and ensuring rigorous protection, with particular focus on safeguarding, mental-capacity assessment, family involvement, and the risk of coercion or abuse being missed under the proposed framework.